| Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 97.05 mm | 97.05 mm | 97.05 mm | 97.05 mm | 97.05 mm | 97.05 mm |
| Cash burn (monthly) | (no burn) | (no burn) | 25.14 mm | 21.70 mm | 17.33 mm | 15.94 mm |
| Cash used (since last report) | n/a | n/a | 101.11 mm | 87.29 mm | 69.69 mm | 64.11 mm |
| Cash remaining | n/a | n/a | -4.06 mm | 9.76 mm | 27.35 mm | 32.93 mm |
| Runway (months of cash) | n/a | n/a | -0.2 | 0.4 | 1.6 | 2.1 |
| 13F holders | Current |
|---|---|
| Total holders | 169 |
| Opened positions | 32 |
| Closed positions | 19 |
| Increased positions | 54 |
| Reduced positions | 47 |
| 13F shares | Current |
|---|---|
| Total value | 1.31 tn |
| Total shares | 149.38 mm |
| Total puts | 39.00 k |
| Total calls | 53.20 k |
| Total put/call ratio | 0.7 |
| Largest owners | Shares | Value |
|---|---|---|
| Venrock Healthcare Capital Partners II | 11.52 mm | $138.32 mm |
| Point72 Asset Management | 10.47 mm | $113.08 bn |
| Kynam Capital Management | 9.24 mm | $99.79 bn |
| FMR | 8.32 mm | $89.85 bn |
| BlackRock | 7.99 mm | $86.31 bn |
| Commodore Capital | 7.54 mm | $81.43 bn |
| TCG Crossover Management | 6.96 mm | $75.22 bn |
| Fairmount Funds Management | 6.23 mm | $67.24 bn |
| Vanguard | 5.71 mm | $61.72 bn |
| VR Adviser | 5.68 mm | $61.39 bn |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 23 Jan 25 | Jessica Sachs | Stock Option Common Stock | Grant | Acquire A | No | No | 8.89 | 270,000 | 2.40 mm | 270,000 |
| 23 Jan 25 | Robbins Andrew R | Stock Option Common Stock | Grant | Acquire A | No | No | 8.89 | 915,000 | 8.13 mm | 915,000 |
| 23 Jan 25 | Evan Kearns | Stock Option Common Stock | Grant | Acquire A | No | No | 8.89 | 230,000 | 2.04 mm | 230,000 |
| 23 Jan 25 | John Edward Robinson | Stock Option Common Stock | Grant | Acquire A | No | No | 8.89 | 270,000 | 2.40 mm | 270,000 |
| 23 Jan 25 | Cole Pinnow | Stock Option Common Stock | Grant | Acquire A | No | No | 8.89 | 240,000 | 2.13 mm | 240,000 |
